| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/22/2009 | CN101411806A Medicament for treating hyperplasia of mammary glands |
| 04/22/2009 | CN101411803A External use medicament for treating psoriasis |
| 04/22/2009 | CN101411792A Medicament for hoarseness and aphonia |
| 04/22/2009 | CN101411788A Method for preparing powder for whitening teeth |
| 04/22/2009 | CN101411784A Compound oral liquid for tonifying blood containing red skin of peanut and preparation technique |
| 04/22/2009 | CN101411775A Chinese medicament preparation for treating oral disease |
| 04/22/2009 | CN101411774A External-use medicament for treating appendicitis |
| 04/22/2009 | CN101411773A External-use Chinese-medicinal liquor for treating cervical vertebra disease |
| 04/22/2009 | CN101411771A Chinese medicine preparation for treating bleeding symptoms and preparation method thereof |
| 04/22/2009 | CN101411764A Use of Chinese medicinal composition in preparing medicament for treating degenerative cardiac valve disease of old age |
| 04/22/2009 | CN101411757A Injection for treating milk cattle mastitis and preparation method thereof |
| 04/22/2009 | CN101411754A Anti-cancer oral liquid |
| 04/22/2009 | CN101411746A Novel use of salvia root extract |
| 04/22/2009 | CN101411745A Antibiotic tanshinone extract, preparation method thereof, use and products produced thereby |
| 04/22/2009 | CN101411742A Capsule for freeing collateral vessels containing astragalus and leech |
| 04/22/2009 | CN101411738A Novel operation antiblocking liquor |
| 04/22/2009 | CN101411735A Quality control method of pharmaceutical composition for preventing and treating coronary heart disease |
| 04/22/2009 | CN101411734A Method for treating hyperosteogeny |
| 04/22/2009 | CN101411723A Method for producing Paphia undulata amino acid oral liquid |
| 04/22/2009 | CN101411720A Fungal medicinal granules for inducing suicide of cancer cell |
| 04/22/2009 | CN101411719A Compound lincomycin hydrochloride injection for livestock and preparation method thereof |
| 04/22/2009 | CN101411718A Composition with antiinflammatory and bacteriostatic functions |
| 04/22/2009 | CN101411717A Composition for treating acute enteritis and diarrhea |
| 04/22/2009 | CN101411716A Use of polygonin for preparing product for resisting dementia |
| 04/22/2009 | CN101411715A Pharmaceutical composition containing acarbose |
| 04/22/2009 | CN101411714A Chemical substance for treating colpitis |
| 04/22/2009 | CN101411713A Compound Nimodipine tablet, and enteric tablet thereof, as well as preparation method thereof |
| 04/22/2009 | CN101411712A 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 04/22/2009 | CN101411711A Composition containing alisol A and alisol A 24-acetic ester and use |
| 04/22/2009 | CN101411710A Pemetrexed disodium freeze-dried injection and preparation method thereof |
| 04/22/2009 | CN101411709A Use of Nifekalant |
| 04/22/2009 | CN101411708A Stable Levosimendan pharmaceutical composition and preparation method thereof |
| 04/22/2009 | CN101411707A Pharmaceutical composition for treating rheumatoid arthritis |
| 04/22/2009 | CN101411706A Pharmaceutical composition for resisting tumor of lung |
| 04/22/2009 | CN101411705A Pharmaceutical composition for preventing and treating atherosclerosis |
| 04/22/2009 | CN101411704A Use of pyrimidine-substituted phenylpropionic acid compound in preparing medicament for preventing and/or treating diabetes |
| 04/22/2009 | CN101411703A Medicinal composition for treating angiocardiopathy |
| 04/22/2009 | CN101411702A Nefopam hydrochloride naproxen sodium compound sustained-release preparation and preparation method thereof |
| 04/22/2009 | CN101411701A Vitamin C microcapsule formulation and preparation method thereof |
| 04/22/2009 | CN101411700A Use of 5,7,4'-trihydroxy flavanone or derivative thereof for analgesia |
| 04/22/2009 | CN101411699A Aceclofenac paracetamol tablet and preparation technique |
| 04/22/2009 | CN101411698A Use of salvia root salvianolic acid A |
| 04/22/2009 | CN101411697A Medicinal composition for treating angiocardiopathy |
| 04/22/2009 | CN101411696A Lysine salt microcapsule formulation and processing technique thereof |
| 04/22/2009 | CN101411695A External-use bactericidal medicine for skin and mucous membrane |
| 04/22/2009 | CN101411693A Oral dosage form for controlled drug release |
| 04/22/2009 | CN101411692A Etoposide dispersible tablet and preparation method thereof |
| 04/22/2009 | CN101411690A 2-methoxyestradiol lipidosome freeze-dried injection and preparation method thereof |
| 04/22/2009 | CN101411689A Danofloxacin mesylate microsphere formulation for livestock and poultry and preparation method thereof |
| 04/22/2009 | CN101411688A Compound lincomycin hydrochloride soluble powder for bird and preparation method thereof |
| 04/22/2009 | CN101411686A Clarithromycin sub-microemulsion injection and preparation method thereof |
| 04/22/2009 | CN101411685A Intravenous anesthetics 2,6-diisopropyl phenol microemulsion composition and method of making the same |
| 04/22/2009 | CN101411684A Injection containing pidotimod sodium salt |
| 04/22/2009 | CN101411683A Breast cream absorbed by skin |
| 04/22/2009 | CN100480700C Maiwei rehmannia-root oral preparation quality control method |
| 04/22/2009 | CN100480440C Method for screening SARS coronaviruses main Protease inhibitors from natural product such as Chinese medicinal materials mixture prepared storeroom |
| 04/22/2009 | CN100480275C Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing the complexes |
| 04/22/2009 | CN100480255C Partial and full agonists of AL adenosine receptors |
| 04/22/2009 | CN100480253C Alkylamino alkoxyl substituted C-glycosylisoflavones and preparing method and the use of the same |
| 04/22/2009 | CN100480250C Bromodihydroartemisinin and preparation method thereof |
| 04/22/2009 | CN100480249C Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase |
| 04/22/2009 | CN100480245C 2-amino-4H-3.1-benzoxazinone-4-keto derivatives for treatment of obesity |
| 04/22/2009 | CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents |
| 04/22/2009 | CN100480238C Compound for generating nucleic acid cross-linking action by induction and preparing method and use thereof |
| 04/22/2009 | CN100480234C N-(N-benzoyl-phenylalanyl)-phenylalanine dipeptide derivative, and preparing method and use thereof |
| 04/22/2009 | CN100480232C L-(-)-moprolol l-(+)-tartrate |
| 04/22/2009 | CN100479863C Correlation of cofilin 1 and resistance to anticancer taxane chemotherapy medicine |
| 04/22/2009 | CN100479861C Intensified additive for chondroitin sulfate capsule formulation and tablet and preparation method thereof |
| 04/22/2009 | CN100479860C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 04/22/2009 | CN100479856C Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds |
| 04/22/2009 | CN100479846C Vitamin C and Lonicera and Forsythia capsule |
| 04/22/2009 | CN100479845C Medicinal composition for treating chronic rhinitis and preparation method thereof |
| 04/22/2009 | CN100479840C Red burn ointment |
| 04/22/2009 | CN100479835C Compound medicine for treating diarrheal irritable bowl syndrome |
| 04/22/2009 | CN100479830C Composition of health products, and preparation and application thereof |
| 04/22/2009 | CN100479829C Medicine composition for curing infantile diarrhea |
| 04/22/2009 | CN100479828C Preparing method for substance of poly pentenol capsule |
| 04/22/2009 | CN100479827C Composition and method |
| 04/22/2009 | CN100479826C Ribavirin eye gel eye medicine and producing process thereof |
| 04/22/2009 | CN100479825C Application of gentiopicroside in preparation of antiviral medicament |
| 04/22/2009 | CN100479824C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| 04/22/2009 | CN100479823C The use of diphosphonate in producing medicine case and the case for increasing bone substance |
| 04/22/2009 | CN100479822C Clozapine encapsulated solid lipid microparticle and preparation process thereof |
| 04/22/2009 | CN100479821C Cefditoren pivoxil dry suspensoid and preparing process thereof |
| 04/22/2009 | CN100479820C Itraconazole liposome and preparation process thereof |
| 04/22/2009 | CN100479819C Composition comprising itraconazole for oral administration |
| 04/22/2009 | CN100479818C A pharmaceutical formulation in the treatment of inner ear diseases and application method thereof |
| 04/22/2009 | CN100479817C The use of Nifuratel for preparing medicine for treating oral cavity infection |
| 04/22/2009 | CN100479816C Gingko total terpene lactone compounded medicinal composition, and preparing method and use thereof |
| 04/22/2009 | CN100479815C Medicine for treating M2 type acute myelogenous leukemia and preparation method of injection thereof |
| 04/22/2009 | CN100479814C Use of accelerated lymphocyte homing agents for manufacture of medicament for treating delayed graft function in tissue transplant |
| 04/22/2009 | CN100479813C Preparation method of capsule possessing antiinflammation, releaving pain and anticancer function |
| 04/22/2009 | CN100479812C A microemulsion preparation of high concentration propofol for anesthetic uses |
| 04/22/2009 | CN100479811C Medicinal composition containing backuchiol for treating female breast cancer |
| 04/22/2009 | CN100479808C Fibrate tablet and production method thereof |
| 04/22/2009 | CN100479807C Medicine conveying system--preparation method of solid nano medicine |
| 04/22/2009 | CN100479806C Nanostructured liposome vector with highly effective antineoplastic activity |
| 04/21/2009 | US7521584 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 04/21/2009 | US7521580 For correcting altered CFTR trafficking and associated impaired chloride (Cl-) ion transport |
| 04/21/2009 | US7521571 Compounds such as 2-thioisosorbide 5-mononitrate or 5,5'-dinitrate-2,2'-dithiodiisosorbide or 2-methylthioisosorbide 5-mononitrate; cardiovascular diseases such as, atherosclerosis, cardiac allograft vasculopathy, and tissue damage due to ischemia and/or to ischemia-reperfusion |